Effect of severe renal impairment on the pharmacokinetics and tolerability of the parenteral endothelin antagonist tezosentanVAN GIERSBERGEN, P. L. M; DINGEMANSE, J.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 261-266, issn 0946-1965, 6 p.Article

Antagonism by naltrexone of the hypotension and bradycardia induced by α-methyldopa in conscious normotensive ratsVAN GIERSBERGEN, P. L. M; DE JONG, W.The Journal of pharmacology and experimental therapeutics. 1988, Vol 244, Num 1, pp 341-347, issn 0022-3565Article

Involvement of neurotransmitters in the nucleus tractus solitarii in cardiovascular regulationVAN GIERSBERGEN, P. L. M; PALKOVITZ, M; DE JONG, W et al.Physiological reviews. 1992, Vol 72, Num 3, pp 789-824, issn 0031-9333Article

Tachykinins and their receptors : pharmacology, biochemistry and molecular biology advance a neuropeptide story to the forefront of scienceBUCK, S. H; VAN GIERSBERGEN, P. L. M; BURCHER, E et al.Neurochemistry international. 1991, Vol 18, Num 2, pp 167-170, issn 0197-0186, 4 p.Article

In vivo and in vitro disposition profile of tezosentan, an intravenous dual endothelin receptor antagonist, in humansTREIBER, A; VAN GIERSBERGEN, P. L. M; DINGEMANSE, J et al.Xenobiotica (London. Print). 2003, Vol 33, Num 4, pp 399-414, issn 0049-8254, 16 p.Article

Effects of dynorphin A(1-13) and of fragments of β-endorphin on blood pressure and heart rate of anesthetized ratsVAN GIERSBERGEN, P. L. M; DE LANG, H; DE JONG, W et al.Canadian journal of physiology and pharmacology. 1991, Vol 69, Num 3, pp 327-333, issn 0008-4212, 7 p.Article

Inhibitory and inductive effects of rifampin on the pharmacokinetics of bosentan in healthy subjectsVAN GIERSBERGEN, P. L. M; TREIBER, A; SCHNEITER, R et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 3, pp 414-419, issn 0009-9236, 6 p.Article

Participation of opiate receptors located in the nucleus tractus solitarii in the hypotension induced by α-methyldopaVAN GIERSBERGEN, P. L. M; ROORDING, P; DE LANG, H et al.Brain research. 1989, Vol 498, Num 1, pp 154-158, issn 0006-8993Article

Possible involvement of brain opioid peptides in clonidine-induced hypotension in spontaneously hypertensive ratsVAN GIERSBERGEN, P. L. M; TIERNEY, S. A. V; WIEGANT, V. M et al.Hypertension (Dallas, Tex. 1979). 1989, Vol 13, Num 1, pp 83-90, issn 0194-911XArticle

The receptors for endothelins and their analogues in SK-N-MC neuroblastoma cellsHUGGINS, J. P; PELTON, J. T; VAN GIERSBERGEN, P. L. M et al.Peptides (New York, NY. 1980). 1994, Vol 15, Num 3, pp 529-536, issn 0196-9781Article

Demonstration of a neurokinin A receptor subtype in transfected fibroblastsHENDERSON, A. K; YAMAMURA, H. I; MAGGI, C. A et al.European journal of pharmacology. Molecular pharmacology section. 1992, Vol 225, Num 2, issn 0922-4106Article

Comt inhibition by tolcapone further improves levodopa pharmacokinetics when combined with a dual-release formulation of levodopa/benserazide: A novel principle in the treatment of Parkinson's diseaseGASSER, U. E; JORGA, K; CREVOISIER, C et al.European neurology. 1999, Vol 41, Num 4, pp 206-211, issn 0014-3022Article

The nigrostriatal dopamine system : role in the development of hypertension in spontaneously hypertensive ratsLINTHORST, A. C. E; VAN GIERSBERGEN, P. L. M; GRAS, M et al.Brain research. 1994, Vol 639, Num 2, pp 261-268, issn 0006-8993Article

MDL 100,458 and MDL 102,288 : two potent and selective glycine receptor antagonists with different functional profilesKEHNE, J. H; BARON, B. M; WHITE, H. S et al.European journal of pharmacology. 1995, Vol 284, Num 1-2, pp 109-118, issn 0014-2999Article

Pharmacological properties of dolasetron, a potent and selective antagonist at 5-HT₃ receptorsMILLER, R. C; GALVAN, M; GITTOS, M. W et al.Drug development research. 1993, Vol 28, Num 1, pp 87-93, issn 0272-4391Article

Affinity of R 396, an NK-2 tachykinin receptor in preparations from different speciesMAGGI, C. A; PATACCHINI, R; ASTOLFI, M et al.Neuropeptides (Edinburgh). 1992, Vol 22, Num 2, pp 93-98, issn 0143-4179Article

α-methyldopa induces a naltrexone-insensitive antinociception and hypomotility in ratsVAN GIERSBERGEN, P. L. M; VAN DUINKERKEN, E; WIEGANT, V. M et al.British journal of pharmacology. 1990, Vol 99, Num 3, pp 467-472, issn 0007-1188Article

β-endorphin and central control of arterial blood pressure during challenge of circulatory homeostasisDE JONG, W; SANDOR, P; COX-VAN PUT, J et al.Resuscitation. 1989, Vol 18, Num 2-3, pp 173-182, issn 0300-9572, 10 p.Article

Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonistBARON, B. M; HARRISON, B. L; TAYLOR, V. L et al.European journal of pharmacology. 1997, Vol 323, Num 2-3, pp 181-192, issn 0014-2999Article

Accelerated communication : [Leu⁹ψ(CH₂NH)Leu¹⁰]-neurokinin A(4-10) (MDL 28,564) distinguishes tissue tachykinin peptide NK₂ receptorsBUCK, S. H; HARBESON, S. L; HASSMANN, C. F et al.Life sciences (1973). 1990, Vol 47, Num 10, pp PL37-PL41, issn 0024-3205Article